SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-040711
Filing Date
2016-11-01
Accepted
2016-11-01 10:27:13
Documents
62
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q oxfd20160818_10q.htm 10-Q 1262406
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 78764
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 14436
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 14143
5 EXHIBIT 32 ex32.htm EX-32 6271
12 a2.jpg GRAPHIC 32183
13 a1.jpg GRAPHIC 47796
  Complete submission text file 0001437749-16-040711.txt   4631850

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS oxfd-20160930.xml EX-101.INS 730136
7 EXHIBIT 101.SCH oxfd-20160930.xsd EX-101.SCH 44093
8 EXHIBIT 101.CAL oxfd-20160930_cal.xml EX-101.CAL 43113
9 EXHIBIT 101.DEF oxfd-20160930_def.xml EX-101.DEF 315500
10 EXHIBIT 101.LAB oxfd-20160930_lab.xml EX-101.LAB 257886
11 EXHIBIT 101.PRE oxfd-20160930_pre.xml EX-101.PRE 328727
Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Filer) CIK: 0001586049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36200 | Film No.: 161963583
SIC: 2835 In Vitro & In Vivo Diagnostic Substances